Download PDFPDF
Are drug eluting stents really worth the money?
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • A rapid response is a moderated but not peer reviewed online response to a published article in a BMJ journal; it will not receive a DOI and will not be indexed unless it is also republished as a Letter, Correspondence or as other content. Find out more about rapid responses.
  • We intend to post all responses which are approved by the Editor, within 14 days (BMJ Journals) or 24 hours (The BMJ), however timeframes cannot be guaranteed. Responses must comply with our requirements and should contribute substantially to the topic, but it is at our absolute discretion whether we publish a response, and we reserve the right to edit or remove responses before and after publication and also republish some or all in other BMJ publications, including third party local editions in other countries and languages
  • Our requirements are stated in our rapid response terms and conditions and must be read. These include ensuring that: i) you do not include any illustrative content including tables and graphs, ii) you do not include any information that includes specifics about any patients,iii) you do not include any original data, unless it has already been published in a peer reviewed journal and you have included a reference, iv) your response is lawful, not defamatory, original and accurate, v) you declare any competing interests, vi) you understand that your name and other personal details set out in our rapid response terms and conditions will be published with any responses we publish and vii) you understand that once a response is published, we may continue to publish your response and/or edit or remove it in the future.
  • By submitting this rapid response you are agreeing to our terms and conditions for rapid responses and understand that your personal data will be processed in accordance with those terms and our privacy notice.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Author's reply
    • Martyn Thomas, Clinical Director of Cardiac Services; BCIS President

    Dear Editor,

    I have read the letter from Professor Walley and colleagues with interest. I have no desire to restate my editorial but would have the following comments.

    Comments such as “data is virtually complete”, “only two patients underwent a second revascularisation in another north-west NHS hospital” and the low diabetes rates “are probably due to ethnicity differences” reflect all the problems of a...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Are drug eluting stents worth the money?
    • Tom Walley, Prof of clinical Pharmacology
    • Other Contributors:
      • Adrian Bagust, Tony Greyson, Raphe Perry

    Dear Editor,

    We wish to respond to criticisms of our paper on the cost effectiveness of drug eluting stents (DES) by Martyn Thomas in his recent editorial.

    The criticisms are that:

    • Our study is based on data of uncertain quality from one centre, which may be biased, and report unusually low rates of diabetes and revascularisation.

    Processes of validation of our data are available on req...

    Show More
    Conflict of Interest:
    None declared.